Skip to Content
Merck
  • Dydrogesterone use during pregnancy: overview of birth defects reported since 1977.

Dydrogesterone use during pregnancy: overview of birth defects reported since 1977.

Early human development (2009-02-06)
Annette Queisser-Luft
ABSTRACT

Between 1977 and 2005, 28 cases of potential links between maternal dydrogesterone use during pregnancy and congenital birth defects were reported. The types of defects were very diverse, with no evidence of a pattern of abnormalities. The data do not provide evidence for congenital malformations associated with dydrogesterone use.

MATERIALS
Product Number
Brand
Product Description

Dydrogesterone, European Pharmacopoeia (EP) Reference Standard